Colorectal Cancer is an esteemed academic journal published by Taylor & Francis Ltd, focusing on all aspects of colorectal cancer research, diagnosis, treatment, and prevention. With an ISSN of 1758-194X and an E-ISSN of 1758-1958, this journal serves as a critical platform for publishing innovative studies, clinical trials, and meta-analyses to advance the understanding of colorectal cancer. Though not yet categorized under open access, it provides valuable insights and is committed to enhancing the visibility of research contributions within the field. The journal aims to foster collaboration and communication among researchers, clinicians, and students dedicated to improving patient outcomes and exploring novel therapeutic strategies. With its rigorous editorial standards, Colorectal Cancer plays a pivotal role in shaping future research and clinical practices, making it indispensable for professionals in oncology, gastroenterology, and related fields.

Urologic Oncology - Seminars and Original Investigations is a premier journal published by Elsevier Science Inc, dedicated to advancing the field of urologic oncology through high-quality, peer-reviewed research and insightful scholarly discussions. With an ISSN of 1078-1439 and an E-ISSN of 1873-2496, this journal has established itself as a vital resource for professionals, researchers, and students alike since its inception in 1995. Currently holding a Q2 ranking in Oncology and a prestigious Q1 in Urology for 2023, it ranks 28th out of 120 in Urology and 177th out of 404 in Oncology within Scopus, underscoring its relevance and impact in these critical fields. While the journal operates under a subscription model, it continues to deliver compelling and transformative research aimed at enhancing patient outcomes in urologic oncology. With a focus on innovative therapies, diagnostic advancements, and clinical trials, the journal contributes significantly to ongoing dialogue and development in urologic health care.

Pediatric Hematology and Oncology, published by Taylor & Francis Inc, serves as a vital platform dedicated to the fields of hematology, oncology, and pediatrics, providing a comprehensive avenue for the dissemination of scholarly research and clinical advancements. With an ISSN of 0888-0018 and an E-ISSN of 1521-0669, this journal has successfully converged its expertise over the years from 1984 to 2024. Ranked in the Q3 category for Hematology and Oncology, alongside a Q2 ranking in Pediatrics, Perinatology, and Child Health (2023), it engages a diverse readership comprising researchers, healthcare professionals, and students eager to explore groundbreaking studies in child health and treatment methodologies. While it currently does not offer Open Access options, the journal is widely cited and recognized, particularly in its specialized fields, fostering a rich environment for dialogue and innovation in the management of pediatric hematological and oncological disorders. The journal is based in the United Kingdom at 530 Walnut Street, Ste 850, Philadelphia, PA 19106, making it an essential resource for those pursuing excellence in pediatric medical research.

Cancers is a leading peer-reviewed journal published by MDPI, dedicated to advancing the field of oncology and cancer research. Established in 2009 and based in Switzerland, this Open Access journal provides a platform for the rapid dissemination of high-quality research findings, reviews, and clinical studies related to all aspects of cancer biology and treatment. With an impressive impact factor and recognized as Q1 in Oncology and Q2 in Cancer Research for 2023, Cancers strives to foster a collaborative environment among researchers, healthcare professionals, and students seeking to deepen their knowledge and understanding of cancer. The journal’s commitment to accessibility and its broad scope make it an invaluable resource for anyone passionate about combating cancer and improving patient outcomes. For more information and to access its diverse publications, visit the journal’s website.

Journal of Cancer is a premier, peer-reviewed academic journal published by IVYSPRING INTERNATIONAL PUBLISHING that focuses on advancing the field of oncology. With an impact factor reflecting its significant contributions, this journal ranks in the 80th percentile of medical journals pertaining to oncology, positioning it at #79 out of 404 in Scopus. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that groundbreaking research reaches a global audience without barriers. Based in Australia, the journal addresses a wide array of topics within cancer research, catering to researchers, healthcare professionals, and students committed to enhancing their understanding of the complexities of cancer. Amidst evolving challenges in oncology, the Journal of Cancer serves as a vital platform for disseminating innovative findings, fostering collaboration, and promoting informed decisions that can lead to improved cancer outcomes worldwide.

Oncology Research and Treatment, published by KARGER, is a highly regarded academic journal dedicated to advancing the field of oncology through rigorous research and clinical insights. With a history spanning from 1978 to 1997 and continuing from 2013 to 2024, this journal provides a vital platform for researchers and professionals in cancer research, hematology, and related disciplines. Though currently listed in the Q3 tier of 2023 for Cancer Research, Hematology, and Oncology, its growing readership and open access policy enhance its visibility and impact within the scientific community. Based in Switzerland, the journal features diverse access options, reflecting the global importance of oncology research. With a focus on innovative treatments and the latest methodologies, Oncology Research and Treatment plays a crucial role in fostering collaboration and dialogue among researchers, professionals, and students alike, helping to shape the future of cancer care and management.

Taiwanese Journal of Obstetrics & Gynecology, published by Elsevier Taiwan, stands as a leading platform in the field of obstetrics and gynecology, fostering academic discourse and innovative research since its inception in 2004. With an impact factor that places it in the Q2 category of its field, it ranks #84 out of 209 journals in Obstetrics and Gynecology according to Scopus, indicating a significant reputation within the medical community. This open access journal ensures wide dissemination of research findings, allowing professionals, researchers, and students alike to stay updated with the latest advancements and practices. The journal's focus on publishing high-quality, peer-reviewed articles covers a broad range of topics within the field, making it an essential resource for those interested in women's health issues, clinical practices, and medical advancements in Taiwan and beyond. With its commitment to excellence, the Taiwanese Journal of Obstetrics & Gynecology invites contributions that enhance the understanding and management of obstetric and gynecological care.

The American Journal of Obstetrics and Gynecology, established in 1920 and published by Mosby-Elsevier, stands as a premier platform for the dissemination of critical research in the field of obstetrics and gynecology. With an impressive Scopus rank of #2 out of 209 journals in its category, placing it in the 99th percentile, this journal is recognized for its significant contributions to clinical practice and academia, as evidenced by its Q1 quartile status for 2023. Aimed at researchers, healthcare professionals, and students, the journal features a wide array of articles addressing contemporary issues, innovative research findings, and evolving practices in women's health and reproductive medicine. Although it does not currently offer open access options, it remains a vital resource for those seeking in-depth analysis and insights within this crucial medical specialty. By bridging the gap between research and clinical implementation, the American Journal of Obstetrics and Gynecology continues to play a pivotal role in shaping the future of obstetric and gynecologic care.

Minerva Obstetrics and Gynecology, an esteemed journal published by EDIZIONI MINERVA MEDICA, serves as a vital resource in the field of obstetrics and gynecology. With an ISSN of 2724-606X and an E-ISSN of 2724-6450, this open access journal aims to disseminate high-quality research and clinical studies that address contemporary challenges and advancements in women's health. Since its inception in 2021, Minerva Obstetrics and Gynecology has garnered recognition within the academic community, achieving a commendable Q3 ranking in the 2023 category of Obstetrics and Gynecology, and placing at the 54th percentile among peers in its Scopus rankings. The journal not only facilitates the exchange of innovative ideas but also encourages collaboration among researchers, healthcare professionals, and students from around the globe. With a commitment to excellence, it aims to address significant topics that impact clinical practice, ensuring that practitioners remain informed about the latest evidence-based practices. For researchers and practitioners aiming to contribute to the advancement of gynecological and obstetric medicine, Minerva Obstetrics and Gynecology represents a prominent platform for publication and engagement.

ORAL ONCOLOGY is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the field of oncology with a specific focus on oral diseases and cancers. Since its inception in 1996, this esteemed journal has provided a platform for high-quality research that addresses critical issues in oral surgery, cancer research, and related disciplines. With impressive rankings in Q1 in Oncology and Q1 in Oral Surgery, and recognized as Rank #1 in Dentistry and Oral Surgery by Scopus, ORAL ONCOLOGY consistently publishes impactful articles that contribute significantly to our understanding of oral cancers. The journal is committed to sharing pioneering findings that enhance clinical practices and improve patient outcomes. As a non-open access journal, it provides readers with exclusive access to cutting-edge research, ensuring that professionals, researchers, and students are at the forefront of developments in the field. Situated in the United Kingdom, ORAL ONCOLOGY serves as an indispensable resource for those dedicated to advancing oral health and oncology research through rigorous scientific inquiry and collaboration.